-
Je něco špatně v tomto záznamu ?
Easy-to-use algorithm would provide faster diagnoses for mucopolysaccharidosis type I and enable patients to receive earlier treatment
A. Tylki-Szymańska, L. De Meirleir, M. Di Rocco, WM. Fathalla, N. Guffon, C. Lampe, AM. Lund, R. Parini, FA. Wijburg, J. Zeman, M. Scarpa,
Jazyk angličtina Země Norsko
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
29797470
DOI
10.1111/apa.14417
Knihovny.cz E-zdroje
- MeSH
- algoritmy * MeSH
- časná diagnóza * MeSH
- dítě MeSH
- hodnocení rizik MeSH
- internacionalita MeSH
- konsensus MeSH
- lidé MeSH
- mukopolysacharidóza I diagnóza terapie MeSH
- multimorbidita MeSH
- novorozenec MeSH
- novorozenecký screening metody MeSH
- předškolní dítě MeSH
- prognóza MeSH
- progrese nemoci MeSH
- retrospektivní studie MeSH
- sexuální faktory MeSH
- stupeň závažnosti nemoci MeSH
- věkové faktory MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
AIM: The aim of this study was to develop an algorithm to prompt early clinical suspicion of mucopolysaccharidosis type I (MPS I). METHODS: An international working group was established in 2016 that comprised 11 experts in paediatrics, rare diseases and inherited metabolic diseases. They reviewed real-world clinical cases, selected key signs or symptoms based on their prevalence and specificity and reached consensus about the algorithm. The algorithm was retrospectively tested. RESULTS: An algorithm was developed. In patients under two years of age, kyphosis or gibbus deformity were the key symptoms that raised clinical suspicion of MPS I and in those over two years they were kyphosis or gibbus deformity, or joint stiffness or contractures without inflammation. The algorithm was tested on 35 cases, comprising 16 Hurler, 10 Hurler-Scheie, and nine Scheie patients. Of these 35 cases, 32 (91%) - 16 Hurler, nine Hurler-Scheie and seven Scheie patients - would have been referred earlier if the algorithm had been used. CONCLUSION: The expert panel developed and tested an algorithm that helps raise clinical suspicion of MPS I and would lead to a more prompt final diagnosis and allow earlier treatment.
Department of Paediatric Neurology and Metabolic Diseases Brussels Belgium
Department of Paediatrics Academic Medical Center Amsterdam The Netherlands
Reference Centre of Metabolic Diseases Hôpital Femme Mère Enfant Bron France
Unit of Rare Diseases Department of Paediatrics IRCCS Giannina Gaslini Genova Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045444
- 003
- CZ-PrNML
- 005
- 20200113082225.0
- 007
- ta
- 008
- 200109s2018 no f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/apa.14417 $2 doi
- 035 __
- $a (PubMed)29797470
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a no
- 100 1_
- $a Tylki-Szymańska, Anna $u Department of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, Warsaw, Poland.
- 245 10
- $a Easy-to-use algorithm would provide faster diagnoses for mucopolysaccharidosis type I and enable patients to receive earlier treatment / $c A. Tylki-Szymańska, L. De Meirleir, M. Di Rocco, WM. Fathalla, N. Guffon, C. Lampe, AM. Lund, R. Parini, FA. Wijburg, J. Zeman, M. Scarpa,
- 520 9_
- $a AIM: The aim of this study was to develop an algorithm to prompt early clinical suspicion of mucopolysaccharidosis type I (MPS I). METHODS: An international working group was established in 2016 that comprised 11 experts in paediatrics, rare diseases and inherited metabolic diseases. They reviewed real-world clinical cases, selected key signs or symptoms based on their prevalence and specificity and reached consensus about the algorithm. The algorithm was retrospectively tested. RESULTS: An algorithm was developed. In patients under two years of age, kyphosis or gibbus deformity were the key symptoms that raised clinical suspicion of MPS I and in those over two years they were kyphosis or gibbus deformity, or joint stiffness or contractures without inflammation. The algorithm was tested on 35 cases, comprising 16 Hurler, 10 Hurler-Scheie, and nine Scheie patients. Of these 35 cases, 32 (91%) - 16 Hurler, nine Hurler-Scheie and seven Scheie patients - would have been referred earlier if the algorithm had been used. CONCLUSION: The expert panel developed and tested an algorithm that helps raise clinical suspicion of MPS I and would lead to a more prompt final diagnosis and allow earlier treatment.
- 650 _2
- $a věkové faktory $7 D000367
- 650 12
- $a algoritmy $7 D000465
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a progrese nemoci $7 D018450
- 650 12
- $a časná diagnóza $7 D042241
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a internacionalita $7 D038622
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mukopolysacharidóza I $x diagnóza $x terapie $7 D008059
- 650 _2
- $a multimorbidita $7 D000076322
- 650 _2
- $a novorozenecký screening $x metody $7 D015997
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a sexuální faktory $7 D012737
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a De Meirleir, Linda $u Department of Paediatric Neurology and Metabolic Diseases, Brussels, Belgium.
- 700 1_
- $a Di Rocco, Maja $u Unit of Rare Diseases, Department of Paediatrics, IRCCS Giannina Gaslini, Genova, Italy.
- 700 1_
- $a Fathalla, Waseem M $u Division of Child Neurology, Department of Pediatrics, Mafraq Hospital, Bani Yas, Abu Dhabi, United Arab Emirates.
- 700 1_
- $a Guffon, Nathalie $u Reference Centre of Metabolic Diseases, Hôpital Femme Mère Enfant (HFME), Bron, France.
- 700 1_
- $a Lampe, Christina $u Center for Rare Diseases, Clinic for Paediatric and Adolescent Medicine, HELIOS Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
- 700 1_
- $a Lund, Allan M $u Centre for Inherited Metabolic Diseases, Departments of Paediatrics and Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- 700 1_
- $a Parini, Rossella $u Rare Metabolic Diseases Unit, Paediatric Clinic, Fondazione MBBM, San Gerardo University Hospital, Monza, Italy.
- 700 1_
- $a Wijburg, Frits A $u Department of Paediatrics, Academic Medical Center, Amsterdam, The Netherlands.
- 700 1_
- $a Zeman, Jiri $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Scarpa, Maurizio $u Center for Rare Diseases, Clinic for Paediatric and Adolescent Medicine, HELIOS Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany. Department of Pediatrics, University of Padova, Padova, Italy.
- 773 0_
- $w MED00009036 $t Acta paediatrica (Oslo, Norway : 1992) $x 1651-2227 $g Roč. 107, č. 8 (2018), s. 1402-1408
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29797470 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113082557 $b ABA008
- 999 __
- $a ok $b bmc $g 1483713 $s 1084117
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 107 $c 8 $d 1402-1408 $e - $i 1651-2227 $m Acta paediatrica (Oslo) $n Acta Paediatr $x MED00009036
- LZP __
- $a Pubmed-20200109